{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T22:34:44Z","timestamp":1773959684540,"version":"3.50.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007353","name":"Fondation J\u00e9r\u00f4me Lejeune","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007353","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universitat de Valencia"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Down syndrome (DS) induces a variable phenotype including intellectual disabilities and early development of Alzheimer\u2019s disease (AD). Moreover, individuals with DS display accelerated aging that affects diverse organs, among them the brain. The Ts65Dn mouse is the most widely used model to study DS. Progressive loss of cholinergic neurons is one of the hallmarks of AD present in DS and in the Ts65Dn model. In this study, we quantify the number of cholinergic neurons in control and Ts65Dn mice, observing a general reduction in their number with age but in particular, a greater loss in old Ts65Dn mice. Increased expression of the m1 muscarinic receptor in the hippocampus counteracts this loss. Cholinergic neurons in the Ts65Dn mice display overexpression of the early expression gene c-fos and an increase in the expression of \u03b2-galactosidase, a marker of senescence. A possible mechanism for senescence induction could be phosphorylation of the transcription factor FOXO1 and its retention in the cytoplasm, which we are able to confirm in the Ts65Dn model. In our study, using Ts65Dn mice, we observe increased cholinergic activity, which induces a process of early senescence that culminates in the loss of these neurons.<\/jats:p>","DOI":"10.1007\/s11064-022-03659-0","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T06:09:44Z","timestamp":1656482984000},"page":"3076-3092","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cholinergic Senescence in the Ts65Dn Mouse Model for Down Syndrome"],"prefix":"10.1007","volume":"47","author":[{"given":"Martina","family":"Kirstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alba","family":"Cambrils","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Segarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Melero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1996-2870","authenticated-orcid":false,"given":"Emilio","family":"Varea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"3659_CR1","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1542\/peds.2009-0745","volume":"124","author":"M Shin","year":"2009","unstructured":"Shin M, Besser LM, Kucik JE et al (2009) Prevalence of Down syndrome among children and adolescents in 10 regions of the United States. Pediatrics 124:1565\u20131571. https:\/\/doi.org\/10.1542\/peds.2009-0745","journal-title":"Pediatrics"},{"key":"3659_CR2","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/ana.410070512","volume":"7","author":"MJ Ball","year":"1980","unstructured":"Ball MJ, Nuttall K (1980) Neurofibrillary tangles, granulovacuolar degeneration, and neuron loss in down syndrome: quantitative comparison with Alzheimer dementia. Ann Neurol 7:462\u2013465. https:\/\/doi.org\/10.1002\/ana.410070512","journal-title":"Ann Neurol"},{"key":"3659_CR3","first-page":"267","volume":"11","author":"M Folin","year":"2003","unstructured":"Folin M, Baiguera S, Conconi MT et al (2003) The impact of risk factors of Alzheimer\u2019s disease in the down syndrome. Int J Mol Med 11:267\u2013270","journal-title":"Int J Mol Med"},{"key":"3659_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/archneur.1995.00540280065020","volume":"52","author":"PR Hof","year":"1995","unstructured":"Hof PR, Bouras C, Perl DP et al (1995) Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down\u2019s syndrome quantitative regional analysis and comparison with Alzheimer\u2019s disease. Arch Neurol 52:379\u2013391","journal-title":"Arch Neurol"},{"issue":"Pt 2","key":"3659_CR5","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1365-2788.2000.00263.x","volume":"44","author":"AJ Holland","year":"2000","unstructured":"Holland AJ, Hon J, Huppert FA, Stevens F (2000) Incidence and course of dementia in people with down\u2019s syndrome: findings from a population-based study. J Intellect Disabil Res 44(Pt 2):138\u2013146","journal-title":"J Intellect Disabil Res"},{"key":"3659_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1034\/j.1601-183X.2003.00026.x","volume":"2","author":"L Nadel","year":"2003","unstructured":"Nadel L (2003) Down\u2019s syndrome: a genetic disorder in biobehavioral perspective. Genes Brain Behav 2:156\u2013166","journal-title":"Genes Brain Behav"},{"key":"3659_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/584071","author":"N Rueda","year":"2012","unstructured":"Rueda N, Fl\u00f3rez J, Mart\u00ednez-Cu\u00e9 C (2012) Mouse models of down syndrome as a tool to unravel the causes of mental disabilities. Neural Plast. https:\/\/doi.org\/10.1155\/2012\/584071","journal-title":"Neural Plast"},{"key":"3659_CR8","first-page":"263","volume":"360","author":"MT Davisson","year":"1990","unstructured":"Davisson MT, Schmidt C, Akeson EC (1990) Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome. Prog Clin Biol Res 360:263\u2013280","journal-title":"Prog Clin Biol Res"},{"key":"3659_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0378-1119(03)00769-8","volume":"318","author":"K Gardiner","year":"2003","unstructured":"Gardiner K, Fortna A, Bechtel L, Davisson MT (2003) Mouse models of down syndrome: how useful can they be? comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions. Gene 318:137\u2013147","journal-title":"Gene"},{"key":"3659_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00335-011-9321-y","volume":"22","author":"X Sturgeon","year":"2011","unstructured":"Sturgeon X, Gardiner KJ (2011) Transcript catalogs of human chromosome 21 and orthologous chimpanzee and mouse regions. Mamm Genome 22:261\u2013271. https:\/\/doi.org\/10.1007\/s00335-011-9321-y","journal-title":"Mamm Genome"},{"key":"3659_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2000-1-2-reviews0002","author":"K Gardiner","year":"2000","unstructured":"Gardiner K, Davisson M (2000) The sequence of human chromosome 21 and implications for research into down syndrome. Genome Biol. https:\/\/doi.org\/10.1186\/gb-2000-1-2-reviews0002","journal-title":"Genome Biol"},{"key":"3659_CR12","doi-asserted-by":"publisher","first-page":"13333","DOI":"10.1073\/pnas.93.23.13333","volume":"93","author":"DM Holtzman","year":"1996","unstructured":"Holtzman DM, Santucci D, Kilbridge J et al (1996) Developmental abnormalities and age-related neurodegeneration in a mouse model of down syndrome. Proc Natl Acad Sci USA 93:13333\u201313338","journal-title":"Proc Natl Acad Sci USA"},{"key":"3659_CR13","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1006\/exnr.1999.7289","volume":"161","author":"AC Granholm","year":"2000","unstructured":"Granholm AC, Sanders LA, Crnic LS (2000) Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of down\u2019s syndrome. Exp Neurol 161:647\u2013663. https:\/\/doi.org\/10.1006\/exnr.1999.7289","journal-title":"Exp Neurol"},{"key":"3659_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0304-3940(98)00641-7","volume":"253","author":"AM Insausti","year":"1998","unstructured":"Insausti AM, Meg\u00edas M, Crespo D et al (1998) Hippocampal volume and neuronal number in Ts65Dn mice: a murine model of down syndrome. Neurosci Lett 253:175\u2013178","journal-title":"Neurosci Lett"},{"key":"3659_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0006-8993(00)01984-3","volume":"858","author":"M Ayberk Kurt","year":"2000","unstructured":"Ayberk Kurt M, Ceri Davies D, Kidd M et al (2000) Synaptic deficit in the temporal cortex of partial trisomy 16 (Ts65Dn) mice. Brain Res 858:191\u2013197. https:\/\/doi.org\/10.1016\/S0006-8993(00)01984-3","journal-title":"Brain Res"},{"key":"3659_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/cne.20337","volume":"480","author":"PV Belichenko","year":"2004","unstructured":"Belichenko PV, Masliah E, Kleschevnikov AM et al (2004) Synaptic structural abnormalities in the Ts65Dn mouse model of down Syndrome. J Comp Neurol 480:281\u2013298. https:\/\/doi.org\/10.1002\/cne.20337","journal-title":"J Comp Neurol"},{"key":"3659_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00702-010-0376-9","volume":"117","author":"D P\u00e9rez-Cremades","year":"2010","unstructured":"P\u00e9rez-Cremades D, Hern\u00e1ndez S, Blasco-Ib\u00e1\u00f1ez JM et al (2010) Alteration of inhibitory circuits in the somatosensory cortex of Ts65Dn mice, a model for down\u2019s syndrome. J Neural Transm 117:445\u2013455. https:\/\/doi.org\/10.1007\/s00702-010-0376-9","journal-title":"J Neural Transm"},{"key":"3659_CR18","doi-asserted-by":"publisher","first-page":"10439","DOI":"10.1073\/pnas.181219298","volume":"98","author":"JD Cooper","year":"2001","unstructured":"Cooper JD, Salehi A, Delcroix JD et al (2001) Failed retrograde transport of NGF in a mouse model of Down\u2019s syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion. Proc Natl Acad Sci USA 98:10439\u201310444. https:\/\/doi.org\/10.1073\/pnas.181219298","journal-title":"Proc Natl Acad Sci USA"},{"key":"3659_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2174\/1567205012666150921095505","volume":"13","author":"ED Hamlett","year":"2016","unstructured":"Hamlett ED, Boger HA, Ledreux A et al (2016) Cognitive impairment, neuroimaging, and Alzheimer neuropathology in mouse models of down syndrome HHS public access. Curr Alzheimer Res 13:35\u201352","journal-title":"Curr Alzheimer Res"},{"key":"3659_CR20","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1126\/science.7046051","volume":"217","author":"RT Bartus","year":"1982","unstructured":"Bartus RT, Dean RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408\u2013414. https:\/\/doi.org\/10.1126\/science.7046051","journal-title":"Science"},{"key":"3659_CR21","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00702-006-0579-2","volume":"113","author":"R Schliebs","year":"2006","unstructured":"Schliebs R, Arendt T (2006) The significance of the cholinergic system in the brain during aging and in Alzheimer\u2019s disease. J Neural Transm 113:1625\u20131644. https:\/\/doi.org\/10.1007\/s00702-006-0579-2","journal-title":"J Neural Transm"},{"key":"3659_CR22","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1136\/jnnp.50.6.775","volume":"50","author":"H Godridge","year":"1987","unstructured":"Godridge H, Reynolds GP, Czudek C et al (1987) Alzheimer-like neurotransmitter deficits in adult down\u2019s syndrome brain tissue. J Neurol Neurosurg Psychiatry 50:775\u2013778. https:\/\/doi.org\/10.1136\/jnnp.50.6.775","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3659_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0304-3940(97)13379-1","volume":"222","author":"C Schneider","year":"1997","unstructured":"Schneider C, Risser D, Kirchner L et al (1997) Similar deficits of central histaminergic system in patients with down syndrome and Alzheimer disease. Neurosci Lett 222:183\u2013186. https:\/\/doi.org\/10.1016\/S0304-3940(97)13379-1","journal-title":"Neurosci Lett"},{"key":"3659_CR24","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s11064-007-9497-4","volume":"33","author":"A Contestabile","year":"2008","unstructured":"Contestabile A, Ciani E, Contestabile A (2008) The place of choline acetyltransferase activity measurement in the \u201ccholinergic hypothesis\u201d of neurodegenerative diseases. Neurochem Res 33:318\u2013327. https:\/\/doi.org\/10.1007\/s11064-007-9497-4","journal-title":"Neurochem Res"},{"key":"3659_CR25","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/brain\/awt372","volume":"137","author":"MF Iulita","year":"2014","unstructured":"Iulita MF, Do Carmo S, Ower AK et al (2014) Nerve growth factor metabolic dysfunction in down\u2019s syndrome brains. Brain 137:860\u2013872. https:\/\/doi.org\/10.1093\/brain\/awt372","journal-title":"Brain"},{"key":"3659_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuron.2006.05.022","volume":"51","author":"A Salehi","year":"2006","unstructured":"Salehi A, Delcroix JD, Belichenko PV et al (2006) Increased app expression in a mouse model of down\u2019s syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron 51:29\u201342. https:\/\/doi.org\/10.1016\/j.neuron.2006.05.022","journal-title":"Neuron"},{"key":"3659_CR27","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1146\/annurev.neuro.24.1.1217","volume":"24","author":"MV Sofroniew","year":"2001","unstructured":"Sofroniew MV, Howe CL, Mobley WC (2001) Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 24:1217\u20131281. https:\/\/doi.org\/10.1146\/annurev.neuro.24.1.1217","journal-title":"Annu Rev Neurosci"},{"key":"3659_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0074-7750(10)39004-5","volume":"39","author":"AJ Esbensen","year":"2010","unstructured":"Esbensen AJ (2010) Health conditions associated with aging and end of life of adults with down syndrome. Int Rev Res Ment Retard 39:107\u2013126. https:\/\/doi.org\/10.1016\/S0074-7750(10)39004-5","journal-title":"Int Rev Res Ment Retard"},{"key":"3659_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/412536","author":"E Head","year":"2012","unstructured":"Head E, Silverman W, Patterson D, Lott IT (2012) Aging and down syndrome. Curr Gerontol Geriatr Res. https:\/\/doi.org\/10.1155\/2012\/412536","journal-title":"Curr Gerontol Geriatr Res"},{"key":"3659_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/mrdd.1025","author":"IT Lott","year":"2001","unstructured":"Lott IT, Head E (2001) Down syndrome and Alzheimer\u2019s disease: A link between development and aging. Ment Retard Dev Disabil Res Rev. https:\/\/doi.org\/10.1002\/mrdd.1025","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"3659_CR31","doi-asserted-by":"publisher","DOI":"10.5114\/fn.2017.68582","author":"M Mulet","year":"2017","unstructured":"Mulet M, Blasco-Ib\u00e1\u00f1ez JM, Crespo C et al (2017) Early increased density of cyclooxygenase-2 (COX-2) immunoreactive neurons in down syndrome. Folia Neuropathol. https:\/\/doi.org\/10.5114\/fn.2017.68582","journal-title":"Folia Neuropathol"},{"key":"3659_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/WNR.0000000000001153","volume":"30","author":"M Bell\u00e9s","year":"2019","unstructured":"Bell\u00e9s M, Carbonell J, Blasco-Ib\u00e1\u00f1ez JM et al (2019) Alterations in reelin and reelin receptors in down syndrome. NeuroReport 30:14\u201318. https:\/\/doi.org\/10.1097\/WNR.0000000000001153","journal-title":"NeuroReport"},{"key":"3659_CR33","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1007\/s00429-015-1164-y","volume":"221","author":"BE Powers","year":"2016","unstructured":"Powers BE, Velazquez R, Kelley CM et al (2016) Attentional function and basal forebrain cholinergic neuron morphology during aging in the Ts65Dn mouse model of down syndrome. Brain Struct Funct 221:4337\u20134352. https:\/\/doi.org\/10.1007\/s00429-015-1164-y","journal-title":"Brain Struct Funct"},{"key":"3659_CR34","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.2144\/03356st02","volume":"35","author":"DP Liu","year":"2003","unstructured":"Liu DP, Schmidt C, Billings T, Davisson MT (2003) Quantitative PCR genotyping assay for the Ts65Dn mouse model of down syndrome. Biotechniques 35:1170\u20131178","journal-title":"Biotechniques"},{"key":"3659_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.npep.2011.10.002","volume":"46","author":"S Hern\u00e1ndez","year":"2012","unstructured":"Hern\u00e1ndez S, Gilabert-Juan J, Blasco-Ib\u00e1\u00f1ez JM et al (2012) Altered expression of neuropeptides in the primary somatosensory cortex of the down syndrome model Ts65Dn. Neuropeptides 46:29\u201337. https:\/\/doi.org\/10.1016\/j.npep.2011.10.002","journal-title":"Neuropeptides"},{"key":"3659_CR36","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0197-4580(93)90112-O","volume":"14","author":"MJ West","year":"1993","unstructured":"West MJ, Abercrombie M, Baddeley AJ et al (1993) New stereological methods for counting neurons. Neurobiol Aging 14:275\u2013285. https:\/\/doi.org\/10.1016\/0197-4580(93)90112-O","journal-title":"Neurobiol Aging"},{"key":"3659_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0006-8993(01)03241-3","volume":"927","author":"J Nacher","year":"2002","unstructured":"Nacher J, Alonso-Llosa G, Rosell D, McEwen B (2002) PSA-NCAM expression in the piriform cortex of the adult rat modulation by NMDA receptor antagonist administration. Brain Res 927:111\u2013121","journal-title":"Brain Res"},{"key":"3659_CR38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1046\/j.1365-2818.1999.00457.x","volume":"193","author":"HJG Gundersen","year":"1999","unstructured":"Gundersen HJG, Jensen EBV, Ki\u00eau K, Nielsen J (1999) The efficiency of systematic sampling in stereology: reconsidered. J Microsci 193:199\u2013211. https:\/\/doi.org\/10.1046\/j.1365-2818.1999.00457.x","journal-title":"J Microsci"},{"key":"3659_CR39","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S0306-4522(00)00526-1","volume":"102","author":"EM Van Lieshout","year":"2001","unstructured":"Van Lieshout EM, Van der Heijden I, Hendriks WJ, Van der Zee CE (2001) A decrease in size and number of basal forebrain cholinergic neurons is paralleled by diminished hippocampal cholinergic innervation in mice lacking leukocyte common antigen-related protein tyrosine phosphatase activity. Neuroscience 102:833\u2013841","journal-title":"Neuroscience"},{"key":"3659_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-13-5","author":"R Guirado","year":"2012","unstructured":"Guirado R, Sanchez-Matarredona D, Varea E et al (2012) Chronic fluoxetine treatment in middle-aged rats induces changes in the expression of plasticity-related molecules and in neurogenesis. BMC Neurosci. https:\/\/doi.org\/10.1186\/1471-2202-13-5","journal-title":"BMC Neurosci"},{"key":"3659_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2020.147031","author":"J Carbonell","year":"2020","unstructured":"Carbonell J, Blasco-Ib\u00e1\u00f1ez JM, Crespo C et al (2020) Piriform cortex alterations in the Ts65Dn model for down syndrome. Brain Res. https:\/\/doi.org\/10.1016\/j.brainres.2020.147031","journal-title":"Brain Res"},{"key":"3659_CR42","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/sj.npp.1301183","volume":"32","author":"E Varea","year":"2007","unstructured":"Varea E, Blasco-Ib\u00e1\u00f1ez JM, G\u00f3mez-Climent MA et al (2007) Chronic fluoxetine treatment increases the expression of PSA-NCAM in the medial prefrontal cortex. Neuropsychopharmacology 32:803\u2013812. https:\/\/doi.org\/10.1038\/sj.npp.1301183","journal-title":"Neuropsychopharmacology"},{"key":"3659_CR43","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1471-4159.2006.03769.x","volume":"97","author":"A Contestabile","year":"2006","unstructured":"Contestabile A, Fila T, Bartesaghi R et al (2006) Choline acetyltransferase activity at different ages in brain of Ts65Dn mice, an animal model for down\u2019s syndrome and related neurodegenerative diseases. J Neurochem 97:515\u2013526. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.03769.x","journal-title":"J Neurochem"},{"key":"3659_CR44","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1007\/s11064-016-2008-8","volume":"41","author":"EB Parisotto","year":"2016","unstructured":"Parisotto EB, Vidal V, Garc\u00eda-Cerro S et al (2016) Chronic melatonin administration reduced oxidative damage and cellular senescence in the hippocampus of a mouse model of down syndrome. Neurochem Res 41:2904\u20132913. https:\/\/doi.org\/10.1007\/s11064-016-2008-8","journal-title":"Neurochem Res"},{"key":"3659_CR45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2006.03971.x","author":"RJ Siarey","year":"2006","unstructured":"Siarey RJ, Kline-Burgess A, Cho M et al (2006) Altered signaling pathways underlying abnormal hippocampal synaptic plasticity in the Ts65Dn mouse model of down syndrome. J Neurochem. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.03971.x","journal-title":"J Neurochem"},{"key":"3659_CR46","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/cne.902850204","volume":"285","author":"EJ Mufson","year":"1989","unstructured":"Mufson EJ, Bothwell M, Hersh LB, Kordower JH (1989) Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: colocalization with cholinergic neurons. J Comp Neurol 285:196\u2013217. https:\/\/doi.org\/10.1002\/cne.902850204","journal-title":"J Comp Neurol"},{"key":"3659_CR47","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0168-0102(03)00005-1","volume":"45","author":"CL Hunter","year":"2003","unstructured":"Hunter CL, Isacson O, Nelson M et al (2003) Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of down\u2019s syndrome. Neurosci Res 45:437\u2013445. https:\/\/doi.org\/10.1016\/S0168-0102(03)00005-1","journal-title":"Neurosci Res"},{"key":"3659_CR48","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/ana.20250","volume":"56","author":"CL Hunter","year":"2004","unstructured":"Hunter CL, Bachman D, Granholm AC (2004) Minocycline prevents cholinergic loss in a mouse model of down\u2019s syndrome. Ann Neurol 56:675\u2013688. https:\/\/doi.org\/10.1002\/ana.20250","journal-title":"Ann Neurol"},{"key":"3659_CR49","first-page":"75","volume":"57","author":"S Greber-Platzer","year":"1999","unstructured":"Greber-Platzer S, Balcz B, Cairns N, Lubec G (1999) c-fos expression in brains of patients with down syndrome. J Neural Transm Suppl 57:75\u201385","journal-title":"J Neural Transm Suppl"},{"key":"3659_CR50","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/153218","author":"J Braudeau","year":"2011","unstructured":"Braudeau J, Dauphinot L, Duchon A et al (2011) Chronic treatment with a promnesiant GABA-A \u03b15 -selective inverse agonist increases immediate early genes expression during memory processing in mice and rectifies their expression levels in a Down syndrome mouse model. Adv Pharmacol Sci. https:\/\/doi.org\/10.1155\/2011\/153218","journal-title":"Adv Pharmacol Sci"},{"key":"3659_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1139\/G07-100","volume":"51","author":"CA Sommer","year":"2008","unstructured":"Sommer CA, Pavarino-Bertelli EC, Goloni-Bertollo EM, Henrique-Silva F (2008) Identification of dysregulated genes in lymphocytes from children with down syndrome. Genome 51:19\u201329. https:\/\/doi.org\/10.1139\/G07-100","journal-title":"Genome"},{"key":"3659_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13395-016-0105-7","volume":"6","author":"S Sugita","year":"2016","unstructured":"Sugita S, Fleming LL, Wood C et al (2016) VAChT overexpression increases acetylcholine at the synaptic cleft and accelerates aging of neuromuscular junctions. Skelet Muscle 6:1\u201317. https:\/\/doi.org\/10.1186\/s13395-016-0105-7","journal-title":"Skelet Muscle"},{"key":"3659_CR53","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.expneurol.2004.11.017","volume":"193","author":"H Seo","year":"2005","unstructured":"Seo H, Isacson O (2005) Abnormal APP, cholinergic and cognitive function in Ts65Dn down\u2019s model mice. Exp Neurol 193:469\u2013480. https:\/\/doi.org\/10.1016\/j.expneurol.2004.11.017","journal-title":"Exp Neurol"},{"key":"3659_CR54","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.bbr.2010.11.058","volume":"221","author":"R Schliebs","year":"2011","unstructured":"Schliebs R, Arendt T (2011) The cholinergic system in aging and neuronal degeneration. Behav Brain Res 221:555\u2013563. https:\/\/doi.org\/10.1016\/j.bbr.2010.11.058","journal-title":"Behav Brain Res"},{"key":"3659_CR55","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1152\/jn.00686.2010","volume":"105","author":"S Dasari","year":"2011","unstructured":"Dasari S, Gulledge AT (2011) M1 and M4 receptors modulate hippocampal pyramidal neurons. J Neurophysiol 105:779\u2013792. https:\/\/doi.org\/10.1152\/jn.00686.2010","journal-title":"J Neurophysiol"},{"key":"3659_CR56","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nn992","volume":"6","author":"SG Anagnostaras","year":"2003","unstructured":"Anagnostaras SG, Murphy GG, Hamilton SE et al (2003) Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice. Nat Neurosci 6:51\u201358. https:\/\/doi.org\/10.1038\/nn992","journal-title":"Nat Neurosci"},{"key":"3659_CR57","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/j.1471-4159.1988.tb02990.x","volume":"50","author":"CJ Smith","year":"1988","unstructured":"Smith CJ, Perry EK, Perry RH et al (1988) Muscarinic cholinergic receptor subtypes in hippocampus in human cognitive disorders. J Neurochem 50:847\u2013856. https:\/\/doi.org\/10.1111\/j.1471-4159.1988.tb02990.x","journal-title":"J Neurochem"},{"key":"3659_CR58","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","volume":"24","author":"EJ Huang","year":"2001","unstructured":"Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:677\u2013736. https:\/\/doi.org\/10.1146\/annurev.neuro.24.1.677","journal-title":"Annu Rev Neurosci"},{"key":"3659_CR59","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/cr.2009.11","volume":"19","author":"SA Mok","year":"2009","unstructured":"Mok SA, Lund K, Campenot RB (2009) A retrograde apoptotic signal originating in NGF-deprived distal axons of rat sympathetic neurons in compartmented cultures. Cell Res 19:546\u2013560. https:\/\/doi.org\/10.1038\/cr.2009.11","journal-title":"Cell Res"},{"key":"3659_CR60","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1750-3639.2007.00113.x","volume":"18","author":"S Guidi","year":"2008","unstructured":"Guidi S, Bonasoni P, Ceccarelli C et al (2008) Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with down syndrome. Brain Pathol 18:180\u2013197. https:\/\/doi.org\/10.1111\/j.1750-3639.2007.00113.x","journal-title":"Brain Pathol"},{"key":"3659_CR61","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/hipo.20308","volume":"17","author":"A Contestabile","year":"2007","unstructured":"Contestabile A, Fila T, Ceccarelli C et al (2007) Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with down syndrome and in Ts65Dn mice. Hippocampus 17:665\u2013678. https:\/\/doi.org\/10.1002\/hipo.20308","journal-title":"Hippocampus"},{"key":"3659_CR62","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ijdevneu.2011.06.001","volume":"29","author":"N Rueda","year":"2011","unstructured":"Rueda N, Fl\u00f3rez J, Mart\u00ednez-Cu\u00e9 C (2011) The Ts65Dn mouse model of down syndrome shows reduced expression of the Bcl-X L antiapoptotic protein in the hippocampus not accompanied by changes in molecular or cellular markers of cell death. Int J Dev Neurosci 29:711\u2013716. https:\/\/doi.org\/10.1016\/j.ijdevneu.2011.06.001","journal-title":"Int J Dev Neurosci"},{"key":"3659_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00075","author":"R L\u00f3pez-Hidalgo","year":"2016","unstructured":"L\u00f3pez-Hidalgo R, Ballest\u00edn R, Vega J et al (2016) Hypocellularity in the murine model for down syndrome Ts65Dn is not affected by adult neurogenesis. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2016.00075","journal-title":"Front Neurosci"},{"key":"3659_CR64","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cell.2017.02.031","volume":"169","author":"MP Baar","year":"2017","unstructured":"Baar MP, Brandt RMC, Putavet DA et al (2017) Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging. Cell 169:132\u2013147. https:\/\/doi.org\/10.1016\/j.cell.2017.02.031","journal-title":"Cell"},{"key":"3659_CR65","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41583-020-0325-z","volume":"21","author":"S Saez-Atienzar","year":"2020","unstructured":"Saez-Atienzar S, Masliah E (2020) Cellular senescence and Alzheimer disease: the egg and the chicken scenario. Nat Rev Neurosci 21:433\u2013444","journal-title":"Nat Rev Neurosci"},{"key":"3659_CR66","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1172\/JCI95145","volume":"128","author":"DJ Baker","year":"2018","unstructured":"Baker DJ, Petersen RC (2018) Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives. J Clin Invest 128:1208\u20131216","journal-title":"J Clin Invest"},{"key":"3659_CR67","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature05529","volume":"445","author":"W Xue","year":"2007","unstructured":"Xue W, Zender L, Miething C et al (2007) Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445:656\u2013660","journal-title":"Nature"},{"key":"3659_CR68","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.molmed.2010.03.003","volume":"16","author":"A Freund","year":"2010","unstructured":"Freund A, Orjalo AV, Desprez PY, Campisi J (2010) Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med 16:238\u2013246","journal-title":"Trends Mol Med"},{"key":"3659_CR69","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1038\/s41467-018-07825-3","volume":"6","author":"Y Ovadya","year":"2018","unstructured":"Ovadya Y, Landsberger T, Leins H et al (2018) Impaired immune surveillance accelerates accumulation of senescent cells and aging. Nat Commun 6:5435","journal-title":"Nat Commun"},{"key":"3659_CR70","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.neuron.2020.09.010","volume":"108","author":"B Pinto","year":"2020","unstructured":"Pinto B, Morelli G, Rastogi M et al (2020) Rescuing over-activated microglia restores cognitive performance in juvenile animals of the Dp(16) mouse model of down syndrome. Neuron 108:887\u2013904","journal-title":"Neuron"},{"key":"3659_CR71","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/378776a0","volume":"378","author":"J Busciglio","year":"1995","unstructured":"Busciglio J, Yankner BA (1995) Apoptosis and increased generation of reactive oxygen species in down\u2019s syndrome neurons in vitro. Nature 378:776\u2013779. https:\/\/doi.org\/10.1038\/378776a0","journal-title":"Nature"},{"key":"3659_CR72","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2174\/138945011796150280","volume":"12","author":"H Lu","year":"2011","unstructured":"Lu H, Huang H (2011) FOXO1: A Potential Target for Human Diseases. Curr Drug Targ 12:1235\u20131244. https:\/\/doi.org\/10.2174\/138945011796150280","journal-title":"Curr Drug Targ"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-022-03659-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-022-03659-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-022-03659-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T21:43:18Z","timestamp":1700775798000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-022-03659-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":72,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["3659"],"URL":"https:\/\/doi.org\/10.1007\/s11064-022-03659-0","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"assertion":[{"value":"19 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the University of Valencia (13-02-2015\/Grant No 2015\/VSC\/PEA\/00046).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}